New approach to graft-versus-host treatment results in improvement for some patients
In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell ...
Nov 30, 2011
0
0